Beijing medical device company developing brain-computer interface and neuromodulation technology, founded in 2025.
Beijing Tianfukang Medical Technology Co., Ltd., trading as Neurorevix, is a medical device company focused on brain-computer interface (BCI) and neuromodulation. Its platform combines BCI with closed-loop nerve bundle modulation, using flexible electrodes, dedicated BCI chips and adaptive closed-loop algorithms. Founded in 2025 and based in Beijing, China, it raised Angel funding in September 2026 led by HSG, with participation from YuanMing Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in